跳至主要内容
临床试验/JPRN-UMIN000001138
JPRN-UMIN000001138已完成1 期

A randomized controlled trial of intra-arterial infusion of CDDP for hepatocellular carcinoma to prevent intra-hepatic metastasis after curative resection - Efficacy of intra-arterial infusion of CDDP after curative resection of hepatocellular carcinoma

iigata Hepatocellular Carcinoma Therapy Study Group0 个研究点目标入组 200 人开始时间: 2008年5月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. The history of severe allergic reaction against iodinated contrast medium and/or platinum-containing drugs. 2. A woman who is pregnant, lactating, or may become pregnant. 3. Hepatocellular carcinoma extended to the first branch of the portal vein or further. 4. Hepatocellular carcinoma extended to the inferior vena cava or further. 5. Dynamic CT or dynamic MRI revealed that hepatocellular carcinoma is solitary and 2 cm or less without vascular invasion. 6. Under interferon therapy. 7. A doctor responsible for the study judged to be inappropriate.

研究者

发起方
iigata Hepatocellular Carcinoma Therapy Study Group

相似试验